Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Pharmacokinetics Guided Natural Products Exploration for Drug Discovery, Development, Delivery and Therapy


   Faculty of Life Sciences

   Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Natural products have emerged as a key standard in novel and safe delivery of anticancer bioactive compounds. Apart from their ease of administration and delivery, natural/phytochemicals still face several hurdles, due to their physiochemical and pharmacokinetic properties. Nowadays, nanotechnology has been widely proposed to deliver herbal drugs, due to its drug delivery system which might potentiate the pharmacological profile of phytochemicals. In the last decade, several studies have been focused on targeting synthetic drugs using polymers.

Several research groups reported the semi-synthetic derivative of natural products with polymers, however, there is a need for research to be done with isolated natural compounds. Polymeric conjugation/encapsulation with poor-bioavailable phytopharmaceuticals might increase their bioavailability and thereby may decrease the dose frequency leading to improved patient compliance. As classical prodrugs, they can accelerate the process of endocytosis to cross the cell membrane and reach their intracellular targets. This is because of their enhanced EPR effect, which can enhance the accumulation of tumour mass. The terminal groups are amenable to specific functionalities and allow molecules to be attached to a phytochemical moiety, resulting in targeted specific, and controlled drug delivery.

With this immense potential and possibilities, the present research work is proposed to overcome the hurdle of natural product delivery using nano formulations. The properties of the nano formulation would be combined with the advantages of nano formulation for targeted delivery of the natural anticancer bioactive compounds.

Objectives

  1. To perform pre-formulation studies of the selected natural bioactive compounds.
  2. To optimise nano-formulation for effective delivery.
  3. To perform the characterization of developed formulation using various analytical techniques and stability studies.
  4. To carry out in vivo and/or in vitro anticancer studies using suitable models for the evaluation of developed nano formulation (s).

How to apply

Formal applications can be submitted via the University of Bradford web site; applicants will need to register an account and select 'Full-time PhD in Pharmacy' as the course, and then specify the project title when prompted.

About the University of Bradford

Bradford is a research-active University supporting the highest-quality research. We excel in applying our research to benefit our stakeholders by working with employers and organisations world-wide across the private, public, voluntary and community sectors and actively encourage and support our postgraduate researchers to engage in research and business development activities.

Faculty of Life Sciences

The faculty comprises a mixture of academic divisions, research centres and outreach facilities. We provide high-quality teaching with a professional focus and engage in cutting-edge research – which we seek to apply through our extensive links with industry and business. We also offer a wide range of postgraduate taught and research courses.

Many of our academics are active researchers and international research experts.

Our interdisciplinary research themes are focus on:

  • Computational and Data-driven Science
  • Interface of Chemistry Biology and Materials
  • Health, Society, People and Place
  • The Life Course

Our research centres include:

  • Centre for Pharmaceutical Engineering Science
  • Digital Health Enterprise Zone
  • Institute of Cancer Therapeutics
  • Wolfson Centre for Applied Research

University investment in research support services, equipment and infrastructure provides an excellent research environment and broad portfolio of developmental opportunities. 

Positive Action Statement

At the University of Bradford our vision is a world of inclusion and equality of opportunity, where people want to, and can, make a difference. We place equality and diversity, inclusion, and a commitment to social mobility at the centre of our mission and ethos. In working to make a difference we are committed to addressing systemic inequality and disadvantages experienced by Black, Asian and Minority Ethnic staff and students.

Under sections 158-159 of the Equality Act 2010, positive action can be taken where protected group members are under-represented. At Bradford, our data show that people from Black, Asian, and Minority Ethnic groups who are UK nationals are significantly under-represented at the postgraduate researcher level. 

These are lawful measures designed to address systemic and structural issues which result in the under-representation of Black, Asian, and Minority Ethnic students in PGR studies.

Chemistry (6) Engineering (12) Medicine (26)

Funding Notes

This is a self-funded PhD project; applicants will be expected to pay their own fees or have a suitable source of third-party funding. Bench fees may apply to this project, in addition to tuition fees. UK students may be able to apply for a Doctoral Loan from Student Finance for financial support.

References

1. Chaturvedi S, Naseem Z, El-Khamisy SF, Wahajuddin M (2022) Nanomedicines targeting the Inflammasome as a promising therapeutic approach for cell senescence. Semin Cancer Biol. 86(2):46-53. PMID: 36030027
2. Singh SK, Rashid M, Bhalala K, Malik Y, Chaturvedi S, Raju KSR, Sultana N, Mitra K, Gayen JR, Wahajuddin M (2021) A Novel Nanosized Phospholipid Complex of Biochanin A for Improving Oral Bioavailability: Preparation and In-vitro/In-vivo Characterizations. Journal of Drug Delivery Science and Technology. 61: 102254
3. Garg A, Tomar DS, Bhalala K, Wahajuddin M (2020) Development and investigation of Artemether loaded binary solid lipid nanoparticles: Physicochemical characterization and in-situ single-pass intestinal permeability. Journal of Drug Delivery Science and Technology. 60: 102072.
4. Chaturvedi S, Malik MY, Rashid M, Singh SK, Tiwari V, Gupta P, Shukla S, Singh S and Wahajuddin M (2020) Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: possible role of nitric oxide isoforms and inflammatory cytokines. NeuroToxicology. 79:1-10. PMID: 32151614
5. Taneja I, Raghuvanshi A, Raju KSR, Awasthi P, Rashid M, Singh S, Goel A, Singh SP, Wahajuddin M (2020) Bioavailability, tissue distribution and excretion studies of a potential anti-osteoporotic agent, medicarpin, in female rats using validated LC-MS/MS method. J Pharm. Biomed. Anal. 180: 112978. PMID 31855725
6. Raju KSR, Rashid M, Gundeti M, Taneja I, Malik MY, Singh SK, Chaturvedi S, Challagundla M, Singh SP, Gayen JR, Wahajuddin M (2019) LC-ESI-MS/MS method for the simultaneous determination of Isoformononetin, daidzein, and equol in rat plasma: Application to a preclinical pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 1129:121776. PMID: 31629309
7. Chaturvedi S, Rashid M, Malik Y, Agarwal A, Singh SK, Gayen JR and Wahajuddin M (2019). Neuropharmacokinetics: A bridging tool between CNS Drug Development and Therapeutic Outcome, Drug Discovery Today, 24 (5): 1166-1175. PMID: 30898661
8. Rashid M, Malik Y, Singh SK. Chaturvedi S, Gayen JR and Wahajuddin M (2019). Bioavailability enhancement of poorly soluble drugs: The Holy Grail in pharma industry, Current Pharmaceutical Design; 25 (9):987-1020. PMID: 30706801
9. Rashid M, Singh SK, Malik MY, Jahan S, Chaturvedi S, Taneja I, Raju KS, Zaiba Naseem, Gayen JR, Wahajuddin M§. Development and validation of UPLC-MS/MS assay for quantification of Cladrin: Absolute bioavailability and dose proportionality study in rats. Journal of Pharmaceutical and Biomedical Analysis, 152, 289-297 PMID: 29454264
10. K Shahad ali, Garg Anuj§, Wahajuddin (2018) Development and evaluation of Chrysin-phospholipid complex loaded solid lipid nanoparticles-storage stability and in vitro anti-cancer activity. Journal of Microencapsulation. 2018 Aug 18; 35(6):600-17

Register your interest for this project



Where will I study?

Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.